GlassScriptPhysician profile
Luis R Urbina
NPI 1609855063
$2,771.87
in general payments reported to CMS, 2019-2025
21 companies · $292 in 2025
The $292 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,856 · 2020: $110 · 2021: $11.56 · 2022: $32.48 · 2023: $46.08 · 2024: $424 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $373 · Travel and Lodging: $356 · Education: $32.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $373.28 |
| Travel and Lodging | $356.09 |
| Education | $32.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $981.85 | 2019 | |
| Intuitive Surgical, INC. | $423.51 | 2024 | |
| Glaxosmithkline, LLC. | $290.40 | 2019-2023 | Trelegy Ellipta |
| Sunovion Pharmaceuticals INC. | $198.29 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $153.58 | 2019-2021 | |
| Davol INC. | $149.40 | 2025 | Progel Applicator Spray Tips |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.07 | 2019 | |
| Medtronic, INC. | $73.12 | 2025 | Illumisite |
| Insmed, INC. | $64.96 | 2022-2023 | Arikayce |
| Genentech USA, INC. | $53.22 | 2019 | |
| Erbe USA INC | $50.00 | 2025 | Cryo2 |
| Novartis Pharmaceuticals Corporation | $47.28 | 2019 | |
| Jazz Pharmaceuticals INC. | $36.47 | 2019-2020 | |
| Pfizer INC. | $26.21 | 2019 | |
| Electromed, INC. | $25.12 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $19.74 | 2025 | Glassia |
| Philips North America LLC | $19.61 | 2019 | |
| Veran Medical Technologies, INC. | $16.40 | 2019 | |
| Mylan Specialty L.P. | $16.20 | 2019 | |
| Grifols USA, LLC | $12.88 | 2019 | |
| Circassia INC. | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Urbina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.